Delivery Order SPE2DE24DA010-SPE2D626F848N
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $5,695.00 from the Defense Logistics Agency's Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes a fixed-price structure with economic price adjustment pricing and was awarded without a set-aside designation through full and open competition. Performance will take place in Santa Clara, California, positioning the award...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain on December 12, 2025, with an ultimate completion date of December 17, 2025. The contract utilizes fixed-price pricing with economic price adjustment and represents a child delivery order under a larger indefinite delivery vehicle. This award was made through full and open competition with no set-aside designation, reflecting...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $9,500 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, reflecting full and open competition. This delivery order represents a discrete procurement action under Abbott Vascular's...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a delivery order award valued at $8,901.70 from the Defense Logistics Agency's Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 10, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation and is for performance in Santa Clara, California. The delivery order represents a task order against Abbott Vascular's larger Indefinite Delivery Contract with the...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $17,250 from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price contract with economic price adjustment provision will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation. As a child entity of Abbott Laboratories Inc., Abbott...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F848NDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order valued at $41,268 under the Defense Logistics Agency's Medical Supply Chain program, awarded on December 5, 2025, with performance completion targeted for December 10, 2025. This fixed-price contract with economic price adjustment mechanism was awarded through full and open competition with no set-aside designation to Abbott Vascular at its Santa Clara, California location. The Defense Logistics Agency Medical Supply Chain functions as a centralized procurement vehicle for the Department of Defense, enabling rapid acquisition of critical medical technologies and supplies across military and veteran healthcare networks. Abbott Vascular has established itself as a strategic supplier to federal healthcare agencies through its extensive portfolio of advanced cardiovascular medical devices, including stents, pacemakers, heart valves, left ventricular assist devices, and transcatheter valve repair systems. The company maintains substantial indefinite delivery contracts with the Defense Logistics Agency and Department of Veterans Affairs across multiple regional networks, including a major $117.1 million cardiovascular procedural packages contract with the Defense Logistics Agency that has generated numerous task orders throughout 2024 and 2025. This delivery order represents a discrete procurement transaction within Abbott's broader federal contracting relationship, supporting the continued supply of specialized cardiovascular technologies essential to military and veteran patient care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.3k | 12/4/25 |